TriSalus Life Sciences (TLSI) Shares Outstanding (Diluted Average) (2020 - 2026)

TriSalus Life Sciences has reported Shares Outstanding (Diluted Average) for 7 years, with the latest figure at $52.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 83.38% year-over-year to $52.3 million; the trailing twelve-month figure through Mar 2026 stood at $52.3 million (up 83.38% YoY), and the FY2025 full-year result was $37.9 million, up 49.61% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $52.3 million, up from $37.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $52.3 million in Q1 2026, with the low at $309609.0 in Q4 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $20.8 million across 5 years, with a median of $23.6 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) plunged 98.75% — and 2024, when it jumped 5497.4%.
• TriSalus Life Sciences' Shares Outstanding (Diluted Average) stood at $309609.0 in 2022, then soared by 2934.71% to $9.4 million in 2023, then jumped by 169.61% to $25.3 million in 2024, then jumped by 49.61% to $37.9 million in 2025, then soared by 38.04% to $52.3 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $52.3 million (Q1 2026), $37.9 million (Q4 2025), and $34.9 million (Q3 2025), per Business Quant data.